6 employees
Sigma Genetics is building a non-invasive device that can deliver charged molecules, such as DNA, RNA, and proteins into patient cells
2016
Sigma Genetics, Inc raised undisclosed on January 27, 2022
Investors: Asymmetry Ventures
Sigma Genetics, Inc raised undisclosed on March 22, 2017
Investors: Y Combinator